Employers Slowly Warm to Point-of-Sale Rebates—But Must Move Faster for Insulin

Employers Slowly Warm to Point-of-Sale Rebates—But Must Move Faster for Insulin

Source: 
Drug Channels
snippet: 

Third-party payers' benefit designs remain a significant barrier to addressing drug costs. Many continue to use the ever-growing rebate dollars of the gross-to-net bubble to offset overall plan costs rather than reducing patient’s out-of-pocket spending.

Point-of-sale (POS) rebates are one possible benefit design solution. POS rebates directly share with patients the discounts that PBMs negotiate with manufacturers.